COMPANY INFO
IQVIA Holdings, Inc., founded in 1982 by Dennis Gillings, is a leading global provider in the contract research organization and pharmaceutical services industry. With approximately 88,000 employees as of 2024, IQVIA operates worldwide from its headquarters in Durham, North Carolina, offering advanced analytics, technology solutions, and clinical research services to the life sciences sector through its website iqvia.com. The company specializes in health information technology, clinical trial management, and commercial outsourcing services, enabling faster drug development and improved healthcare outcomes globally.
IQVIA Holdings, Inc. is a global leader in contract research organization, pharmaceutical services, and health information technology, founded in 1982 by Dennis Gillings. Headquartered in Durham, North Carolina, the company employs approximately 88,000 people as of 2024. IQVIA provides advanced analytics, technology solutions, and clinical research services to the life sciences sector, enabling faster drug development and improved healthcare outcomes. Their offerings cover health IT, clinical trial management, and commercial outsourcing, serving clients worldwide.
IQVIA Holdings, Inc. funding history reflects a distinctive approach primarily centered on grant (prize money) rounds, with total IQVIA Holdings, Inc. funding reaching $1.74 million across six funding rounds. Key milestones include a significant Unattributed round in 2006 and multiple grant rounds supported primarily by the European Union. The grants have been instrumental for ongoing research and project development. Unlike typical venture capital-backed startups, IQVIA Holdings, Inc. investments and funding strategy focus on strategic grants and early-stage unattributed funding rather than traditional venture capital rounds.
IQVIA Holdings, Inc. received a grant (prize money) for ongoing research or project funding, supported by the European Union.
This round aimed to provide project support, with the European Union as the lead investor.
Another grant focused on supporting specific research projects and initiatives, backed by the European Union.
Project funding support to advance research capabilities, with the European Union as the main investor.
European Union issued this grant round for project support and developmental initiatives.
This unattributed IQVIA Holdings, Inc. funding round, likely representing seed or early-stage capital, is their largest recorded to date, with investors not publicly disclosed.
A leading private equity firm, Leonard Green and Partners has a history of backing large-scale healthcare and service-based companies, supporting IQVIA Holdings, Inc. in key stages of growth and transformation.
Fisher Lynch Capital specializes in partnered, long-term private equity investments, playing a strategic role in providing capital and guidance for IQVIA Holdings, Inc.'s major development phases.
Bain Capital Private Equity is a global investment firm recognized for supporting innovation in healthcare and analytics. They have played a part in IQVIA Holdings, Inc.’s funding journey, adding value through financial resources and industry expertise.
The European Union has been a consistent source of grant funding for IQVIA Holdings, Inc., contributing to multiple rounds focused on research, innovation, and project support within the health and life sciences sectors.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching IQVIA Holdings, Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.